Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Statins may be linked to reproductive organ conditions, and their risks should be monitored.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

The conference reported improvements in muscle volume, skin cancer diagnosis, facial and vaginal rejuvenation, and hair growth using various laser treatments.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Oral contraceptives with CPA improve overall quality of life for women with PCOS.

The document explains how male reproductive hormones work and affect the body.

The Princeton III Consensus recommends assessing cardiovascular risk in men with erectile dysfunction and prioritizing heart health before treating ED, especially in those with potential heart disease.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Natesto nasal gel improves erectile function and mood in men with low testosterone within 30 days.

Finasteride reduces corpus cavernosum weight but doesn't affect erectile response in rats.

DA-9401 protects against hair loss, improves organ function, and prevents infertility caused by finasteride.

Former finasteride users showed higher rates of depression and suicidal thoughts compared to those who never used it.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Hand preference and sexual orientation may predict finasteride side effects in male hair loss.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Finasteride may cause lasting sexual side effects, but more research is needed.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Finasteride may cause long-lasting sexual side effects.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.